A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 - results from a multi-center survey.

Christoph StraubeKerstin A KesselFriederike Schmidt-GrafSandro M KriegBernhard MeyerJens GemptStephanie E Combs

Published in: BMC cancer (2018)

Neurooncologists do adapt results from clinical trials quickly. None the less, there is still an immense heterogeneity within the treatment recommendations, predominantly for astrocytic LGGs. Well planned clinical trials and concise treatment recommendations are warranted; additionally, individual counseling of patients is essential.

Keyphrases

clinical trial
low grade
high grade
randomized controlled trial
newly diagnosed
ejection fraction
combination therapy
clinical practice
cross sectional
smoking cessation
patient reported
phase iii